MetLife Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.79M Buy
49,478
+331
+0.7% +$33.9K 0.02% 636
2025
Q4
$5.22M Sell
49,147
-2,605
-5% -$302K 0.03% 611
2025
Q3
$6.57M Sell
51,752
-2,505
-5% -$298K 0.03% 505
2025
Q2
$6.65M Sell
54,257
-1,658
-3% -$189K 0.04% 450
2025
Q1
$5.66M Sell
55,915
-847
-1% -$82.7K 0.03% 548
2024
Q4
$5.24M Buy
56,762
+4,784
+9% +$470K 0.03% 534
2024
Q3
$5.02M Sell
51,978
-1,010
-2% -$90.8K 0.03% 522
2024
Q2
$4.55M Sell
52,988
-2,329
-4% -$195K 0.03% 545
2024
Q1
$4.57M Sell
55,317
-1,447
-3% -$106K 0.03% 533
2023
Q4
$3.79M Sell
56,764
-925
-2% -$59.9K 0.03% 631
2023
Q3
$3.87M Sell
57,689
-2,630
-4% -$181K 0.03% 577
2023
Q2
$4.08M Sell
60,319
-833
-1% -$52.2K 0.03% 572
2023
Q1
$3.31M Sell
61,152
-1,636
-3% -$95.2K 0.02% 690
2022
Q4
$3.76M Sell
62,788
-1,253
-2% -$68.1K 0.03% 602
2022
Q3
$2.9M Sell
64,041
-17,492
-21% -$875K 0.02% 707
2022
Q2
$3.64M Sell
81,533
-2,443
-3% -$125K 0.03% 618
2022
Q1
$4.75M Buy
83,976
+23,370
+39% +$1.22M 0.03% 567
2021
Q4
$3.15M Buy
60,606
+519
+0.9% +$26.8K 0.03% 655
2021
Q3
$3.59M Sell
60,087
-2,435
-4% -$153K 0.03% 541
2021
Q2
$3.88M Sell
62,522
-1,931
-3% -$129K 0.03% 529
2021
Q1
$4.2M Sell
64,453
-3,942
-6% -$257K 0.04% 481
2020
Q4
$4.5M Sell
68,395
-3,175
-4% -$187K 0.04% 406
2020
Q3
$3.7M Sell
71,570
-2,633
-4% -$135K 0.04% 432
2020
Q2
$3.66M Buy
74,203
+3,059
+4% +$165K 0.04% 422
2020
Q1
$3.62M Hold
71,144
0.05% 358
2019
Q4
$3.92M Sell
71,144
-975
-1% -$52.9K 0.04% 476
2019
Q3
$3.63M Sell
72,119
-1,498
-2% -$75.3K 0.04% 494
2019
Q2
$3.71M Sell
73,617
-2,043
-3% -$99.2K 0.04% 500
2019
Q1
$3.52M Sell
75,660
-163
-0.2% -$8.26K 0.04% 527
2018
Q4
$3.72M Sell
75,823
-259
-0.3% -$14.7K 0.05% 402
2018
Q3
$4.72M Buy
+76,082
New +$4.63M 0.05% 384
2018
Q1
Sell
-135,764
Closed -$5.34M 2207
2017
Q4
$5.34M Buy
+135,764
New +$5.16M 0.06% 301

Other funds holding EHC